​​

Testing efficacy at different stages of disease, with support of a grant from the National Institutes of Health.

​

Validating efficacy & safety with dosing studies.

​

On-boarding more medical and biotech partners and advisors.

​

Continuing IP development.

​

Implementing GMP.